Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
GMED 
Globus Medical (GMED)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
03/27/2025: GMED (2-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -9.01% | Avg. Invested days 47 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 03/27/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 9.98B USD | Price to earnings Ratio 96.73 | 1Y Target Price 98.08 |
Price to earnings Ratio 96.73 | 1Y Target Price 98.08 | ||
Volume (30-day avg) 1383447 | Beta 1.19 | 52 Weeks Range 49.33 - 94.93 | Updated Date 03/30/2025 |
52 Weeks Range 49.33 - 94.93 | Updated Date 03/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.75 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 4.09% | Operating Margin (TTM) 18.95% |
Management Effectiveness
Return on Assets (TTM) 5.33% | Return on Equity (TTM) 2.52% |
Valuation
Trailing PE 96.73 | Forward PE 21.1 | Enterprise Value 9625777562 | Price to Sales(TTM) 3.96 |
Enterprise Value 9625777562 | Price to Sales(TTM) 3.96 | ||
Enterprise Value to Revenue 3.82 | Enterprise Value to EBITDA 20.32 | Shares Outstanding 115112000 | Shares Floating 114224212 |
Shares Outstanding 115112000 | Shares Floating 114224212 | ||
Percent Insiders 0.75 | Percent Institutions 97.81 |
Analyst Ratings
Rating 4 | Target Price 97.85 | Buy 5 | Strong Buy 5 |
Buy 5 | Strong Buy 5 | ||
Hold 5 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Globus Medical
Company Overview
History and Background
Globus Medical was founded in 2003 and is headquartered in Audubon, Pennsylvania. It has grown from a spinal implant company to a diversified musculoskeletal company.
Core Business Areas
- Spine: Globus Medical develops and commercializes a broad range of spinal implants and instruments used in various spinal surgeries.
- Trauma: Focuses on providing products and solutions for the treatment of bone fractures and other traumatic injuries.
- Enabling Technologies: Develops and markets robotic and navigation systems for surgical procedures.
- Biologics: Offers a range of biological products used to promote bone healing and tissue regeneration.
Leadership and Structure
Globus Medical is led by a team of experienced executives, with David Paul as Executive Chairman. The organizational structure is divided into business units focusing on spine, trauma, enabling technologies, and biologics.
Top Products and Market Share
Key Offerings
- REFLEXX Plate: A cervical cage that has a market share in the cervical fusion market. Main competitors include Medtronic and Nuvasive. Revenue associated with this specific product is difficult to source, but it contributes a portion to the total spine segment revenue.
- EXCELLERE TLIF Curved Retractor System: A spinal retractor system used in transforaminal lumbar interbody fusion (TLIF) procedures. The main competitors include Stryker and DePuy Synthes. Revenue associated with this specific product is difficult to source, but it contributes a portion to the total spine segment revenue.
- ROSA Robotics Platform: A robotic surgical system used in spine procedures. Competitors include Medtronic's Mazor X Stealth Edition and Stryker's Mako system. Revenue associated with this specific product is difficult to source but is growing as adoption of robotics increases in spine surgery.
Market Dynamics
Industry Overview
The musculoskeletal device industry is characterized by technological innovation and a growing demand for minimally invasive surgical procedures. It is driven by an aging population and increasing incidence of spinal disorders and traumatic injuries.
Positioning
Globus Medical is a key player in the musculoskeletal device industry, known for its innovative product portfolio and its focus on enabling technologies like robotics. They compete with larger, more established companies.
Total Addressable Market (TAM)
The musculoskeletal device market is estimated to be over $40 billion. Globus Medical is well-positioned to capture a larger share of this market through its expanding product portfolio.
Upturn SWOT Analysis
Strengths
- Innovative product portfolio
- Strong focus on enabling technologies (robotics)
- Vertically integrated manufacturing
- Rapid revenue growth
Weaknesses
- Smaller size compared to larger competitors
- Reliance on key products
- Higher R&D expenses
- Product recalls may be problematic for new robotic launches
Opportunities
- Expanding robotic surgery market
- Acquisitions and partnerships
- Geographic expansion
- Aging population driving demand
Threats
- Intense competition
- Price pressure from healthcare providers
- Regulatory changes
- Product liability lawsuits
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- SYK
Competitive Landscape
Globus Medical competes with larger, more established companies like Medtronic, Johnson & Johnson, and Stryker. Globus differentiates itself through innovation, vertically integrated manufacturing, and a focus on enabling technologies.
Major Acquisitions
NuVasive
- Year: 2023
- Acquisition Price (USD millions): 3000
- Strategic Rationale: Expanded product portfolio and market presence in spine and enabling technologies. This also gave them access to Pulse platform
Growth Trajectory and Initiatives
Historical Growth: Globus Medical has experienced significant growth in revenue and market share over the past decade.
Future Projections: Analysts expect Globus Medical to continue to grow at a rapid pace in the coming years, driven by increasing demand for its products and services.
Recent Initiatives: Recent initiatives include expanding its robotic surgery platform, launching new products, and pursuing strategic acquisitions.
Summary
Globus Medical is a rapidly growing musculoskeletal company focused on spine and enabling technologies. Its innovative products, vertically integrated manufacturing, and strong financial performance position it well for future success. However, it faces intense competition and must manage its R&D investments effectively. Post Nuvasive aquisition, the company is primed to grow even more substantially. Despite challenges it is performing very well.
Similar Companies
- MDT
- JNJ
- SYK
- ZBH
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Analyst Reports
- Company Website
- Market Research Reports
Disclaimers:
This analysis is based on publicly available information and analyst estimates. It should not be considered financial advice. Investment decisions should be based on individual research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Globus Medical
Exchange NYSE | Headquaters Audubon, PA, United States | ||
IPO Launch date 2012-08-03 | President, CEO & Director Mr. Daniel T. Scavilla | ||
Sector Healthcare | Industry Medical Devices | Full time employees 5300 | Website https://www.globusmedical.com |
Full time employees 5300 | Website https://www.globusmedical.com | ||
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.